BRIEF published on 11/08/2024 at 07:28, 13 days 7 hours ago Fabasoft AG Reports a Successful First Half of Fiscal Year 2024/2025 Financial Results Revenue Growth Recurring Revenue AI Investments Fabasoft AG
PRESS RELEASE published on 11/08/2024 at 07:23, 13 days 7 hours ago Fabasoft AG: Fabasoft successfully continues its growth and investment path Fabasoft AG reports 7.7% revenue growth to EUR 42.5 million in the first half of fiscal year 2024/2025. Recurring revenues increase by 14.8% with investments in AI solutions Financial Results Revenue Growth AI Solutions Fabasoft AG Recurring Revenues
BRIEF published on 11/04/2024 at 09:35, 17 days 4 hours ago Fabasoft AG Acquires Office Building in Linz Project Financing Fabasoft AG Office Acquisition Corporate Expansion Real Estate Linz
PRESS RELEASE published on 11/04/2024 at 09:30, 17 days 5 hours ago Fabasoft AG: Fabasoft acquires office building in Linz Fabasoft AG strengthens its presence in Linz by acquiring an office building through newly formed project company. Purchase agreement signed for EUR 15 million Acquisition Real Estate Fabasoft AG Office Building Linz
BRIEF published on 08/13/2024 at 19:04, 3 months 7 days ago Fabasoft AG Announces Share Buyback Program Regulatory Compliance Share Buyback Stock Purchase Fabasoft AG AGM Authorization
BRIEF published on 08/13/2024 at 19:04, 3 months 7 days ago Fabasoft AG Announces Share Buyback Plan Share Buyback Regulation Stock Market Fabasoft AG EU 596/2014
PRESS RELEASE published on 08/13/2024 at 18:59, 3 months 7 days ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback Fabasoft AG announces resolution for share buyback program to acquire treasury shares up to 2 million euros, starting on 15 August 2024 Share Buyback Treasury Shares Fabasoft AG Resolution EUR 2,000,000.00
PRESS RELEASE published on 08/13/2024 at 18:59, 3 months 7 days ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback Fabasoft AG announces resolution to acquire treasury shares under share buyback program as approved by the Annual General Meeting. Total volume EUR 2,000,000.00 Annual General Meeting Share Buyback Treasury Shares Fabasoft AG EUR 2,000,000.00
BRIEF published on 08/09/2024 at 07:29, 3 months 12 days ago Fabasoft AG Achieves Revenue Growth in First Quarter of 2024/2025 Financial Results Revenue Growth Artificial Intelligence 2024/2025 Fabasoft
PRESS RELEASE published on 08/09/2024 at 07:24, 3 months 12 days ago Fabasoft AG: Fabasoft achieves revenue growth in the first quarter of 2024/2025 Fabasoft AG achieves revenue growth of 3.8% in Q1 2024/2025, with total sales revenue of EUR 20.4 million. Focus on AI innovation and product development for continued growth AI Innovation Revenue Growth Fabasoft AG Product Development Q1 2024/2025
Published on 11/21/2024 at 14:15, 15 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 30 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 30 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 30 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 14 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 15 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 55 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 32 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 10 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 45 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 45 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
